Latest News for: statistical significance

Edit

IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab) for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed (Form 8-K) (IO Biotech Inc)

Public Technologies 11 Aug 2025
IO Biotech Announces Clinical Improvement in Progression Free Survival Demonstrated in Pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (Pembrolizumab)for the Treatment of First-line Advanced Melanoma, but Statistical Significance Narrowly Missed •.
Edit

Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Statistically Significant Weight Reduction and a Safety Profile Consistent with Injectable GLP-1 Medicines in Phase III ATTAIN-1 in Adults with Obesity) (Chugai Pharmaceutical Co Ltd)

Public Technologies 08 Aug 2025
). August 8, 2025 ... Code number ... Tel ... Eli Lilly's Announcement Regarding Oral GLP-1 Orforglipron (Statistically Significant Weight Reduction and a Safety Profile Consistent with Injectable GLP-1 Medicines in Phase III ATTAIN-1 in Adults with Obesity) ... ###.
Edit

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, ...

Brattleboro Reformer 06 Aug 2025
Presentations showcased at World Transplant Congress in San Francisco demonstrate HOPE reduces the cost of liver transplantation by shortening the index hospitalization and decreasing late complications ....
Edit

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

PR Newswire 06 Aug 2025
HOPE was associated with significantly less severe organ rejection and a significantly lower risk of steroid resistant organ rejection ... a significantly lower risk of steroid resistant organ rejection.
Edit

The psychological burden of statistical significance in academic publishing

Phys Dot Org 31 Jul 2025
A new paper published in European ...
Edit

Radella Pharmaceuticals Announces New Obesity Trial Data Showing Statistically Significant Weight Loss and Broader Cardiometabolic Benefits

PR Newswire 31 Jul 2025
In healthy subjects with elevated LDL cholesterol levels, MD-18 demonstrated a statistically significant decrease in LDL cholesterol vs ... Further, MD-18 demonstrated a statistically significant decrease in alanine aminotransferase (ALT) levels vs.
Edit

NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s ...

Nasdaq Globe Newswire 30 Jul 2025
-- Pre-specified analysis shows obicetrapib significantly ...
Edit

NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025 (Form 8-K) (NewAmsterdam Pharma Company NV)

Public Technologies 30 Jul 2025
NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer's Disease Biomarkers at AAIC 2025 ... NewAmsterdam observed statistically ...
Edit

Gefurulimab dual-binding nanobody demonstrated statistically significant and clinically meaningful improvement in functional activities of daily living in adults with generalised myasthenia gravis in PREVAIL Phase III trial (AstraZeneca plc)

Public Technologies 24 Jul 2025
) Once-weekly self-administered subcutaneous C5 inhibitor showed statistically significant and clinically meaningful reduction in disease severity at week 26 ... Data demonstrated a statistically ...
Edit

Once-weekly self-administered subcutaneous C5 inhibitor showed statistically significant and clinically meaningful reduction in disease severity at week 26 (Form 6-K) (AstraZeneca plc)

Public Technologies 24 Jul 2025
Gefurulimab dual-binding nanobody demonstrated statistically significant and clinically meaningful improvement in functional activities of daily living in adults with generalised myasthenia gravis in PREVAIL Phase III trial.
Edit

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in ...

The Galveston Daily News 21 Jul 2025
WILMINGTON, Del.--(BUSINESS WIRE)--Jul 21, 2025-- ....
Edit

TAGRISSO® (osimertinib) plus chemotherapy demonstrated statistically significant and clinically meaningful improvement in overall survival in EGFR-mutated advanced lung cancer (AstraZeneca Pharmaceuticals LP)

Public Technologies 21 Jul 2025
Positive high-level results from the final overall survival (OS) analysis of the FLAURA2 Phase III trial showed AstraZeneca's TAGRISSO® (osimertinib) with the addition of pemetrexed and platinum-based ...
Edit

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure ...

Business Wire 17 Jul 2025
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq.
Edit

DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer (Form 8-K) (DiaMedica Therapeutics Inc)

Public Technologies 17 Jul 2025
Statistically Significant Reductions in Blood Pressure and No Placental Transfer ... DM199 Demonstrated Highly Statistically Significant and Clinically Meaningful Reductions in Systolic and Diastolic Blood Pressure for Combined Cohorts 6-9.
Edit

30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased

The Eagle-Tribune 16 Jul 2025
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Jul 16, 2025-- ... .

Article Search

tools
×
×
×
×